Class II Recall With Six Bottles in the Return Bin

Class II means temporary or medically reversible harm is possible - not that nothing is required.

• Pull 4 bottles of K2214 and 2 bottles of K2215 off the shelf immediately and quarantine them in a locked, labeled Do Not Dispense / RECALLED area, separate from regular returns.
• Sweep the whole pharmacy, not just the shelf: the return bin, will-call, the crash cart, automated dispensing cabinets, satellite/off-site locations, and any transferred stock.
• Pull the dispensing history for the 37 bottles/29 patients so a complete accountability list exists (patient, date, quantity, prescriber).
• Respond to the recall notice - complete the consignee response/acknowledgment with quantities on hand and quantities already dispensed, and return it to the recall coordinator by the stated deadline.
• Notify prescribers of affected patients: subpotency means possible therapeutic failure, which is a clinical message, not just an inventory message. Patient contact typically follows prescriber direction.
• Document every step with date, time, and initials.

"Only Class II" is exactly the assumption that turns a routine recall into a failed effectiveness check.

They are not saleable inventory and must not be laundered through the normal return stream.

• The bottles were returned by a patient and never restocked - correct handling of that return is the reason they are still separate. They should not be re-entered into stock, and they must not be put into a normal credit return where they could be treated as saleable.
• Treat them as recalled product: quarantine with the rest, include them in the recall accountability count (6 units), and disposition them per the recall instructions - return to the manufacturer/recall processor if directed, or destroy per policy if that is what the notice specifies.
• If the wholesaler's recall process requires the credits to run separately from routine returns, keep them separate; mixing them risks a credit rejection or, worse, a recalled unit re-entering commerce.
• Document the source (patient return), condition (unopened), quantity, and final disposition.

General rule the scenario illustrates: a patient return never goes back to the shelf, and a recalled unit never goes back into a credit carton without being identified as recalled.

Unaffected lots stay - with evidence that they are unaffected.

• K2214 and K2215 only. Verify by lot number from the actual packages, not from the wholesaler's invoice history, and confirm no unlabeled or repackaged stock is in the drawer.
• Keep the unaffected lots available for dispensing and note in the quarantine log that they were screened and released.

Closing the recall requires:

• The completed consignee response with accurate on-hand and dispensed quantities, plus final disposition for every unit (returned, destroyed, or accounted for as dispensed).
• Reconciliation: 4 + 2 on shelf + 6 from the return bin + 37 dispensed = the quantity received from the wholesaler for those lots. If it does not reconcile, keep looking.
• Records retained per policy and state requirement (commonly at least 2 years), including the recall notice, the response, the patient/prescriber list, and the return or destruction documentation.
• Respond to the effectiveness check when the recall coordinator contacts you - an unanswered effectiveness check is the most common way a pharmacy gets flagged.